Reports

Find out about us through our annual reports, financial statements and reviews, or read other reports about our work.

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

Refine results:

Clear all

    Report 20 May 2020 Updated 3 July 2020

    What people think about global access to COVID-19 treatments and vaccines

    [Summary] Our polling of more than 6,000 adults in the UK, the USA, Germany and France shows strong public support for making sure that any new coronavirus treatments and vaccines are first made available to those who need them most.

    Report 14 October 2019 Updated 14 July 2020

    Reframing Resistance

    [Summary] This report aims to help experts and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

    Report 19 September 2019 Updated 4 December 2019

    Advancing epidemics R&D to keep up with a changing world

    DownloadPDF 854KB

    This paper examines the status, progress and challenges in research and development for epidemics. It was developed to feed into the first annual report of the Global Preparedness Monitoring Board.

    Report 8 March 2019 Updated 4 December 2019

    Call to Action on Antimicrobial Resistance 2018 Report

    DownloadPDF 1.4MB

    Key outcomes from the second Call to Action on Antimicrobial Resistance held in Ghana, co-hosted by the Governments of Ghana, Thailand and the UK, along with the World Bank, UN Foundation and Wellcome.

    Report 11 December 2018 Updated 4 December 2019

    Addressing antimicrobial resistance in the environment

    DownloadPDF 1.9MB

    This scientific white paper looks at the evidence about how antimicrobial resistance in the environment is impacting human health, and at how the risks can be addressed. It summarises discussions from the International Environmental AMR forum, held in April 2018.

    Report 11 December 2018 Updated 4 December 2019

    Addressing antimicrobial resistance in the environment: executive summary

    DownloadPDF 638KB

    A summary of the findings of our scientific white paper, which looks at the evidence about how antimicrobial resistance in the environment is impacting human health, and at how the risks can be addressed.

    Report 5 September 2018 Updated 4 December 2019

    Antimicrobial resistance surveillance: sharing industry data

    DownloadPDF 1.1MB

    Recommendations from a pilot project to openly publish human antimicrobial resistance surveillance data generated and collected by the pharmaceutical industry. The project was led by the Open Data Institute and funded by Wellcome.

    Report 1 May 2018 Updated 4 December 2019

    Joint statement on International Environmental Antimicrobial Resistance Forum

    DownloadPDF 317KB

    summary of the discussions at the forum, which looked at opportunities to better understand and help reduce the impact of environmental AMR on human health.

    Report 1 November 2017 Updated 4 December 2019

    Call to Action on Antimicrobial Resistance 2017 Report

    DownloadPDF 1.9MB

    The key outcomes from the Call to Action on Antimicrobial Resistance event, organised by Wellcome in partnership with the UK, Ghanaian and Thai governments and the UN Foundation.

    Report 1 July 2017 Updated 4 December 2019

    Longitudinal population studies strategy

    DownloadPDF 166KB

    Our new strategy for funding longitudinal population studies.

    Report 1 October 2016 Updated 4 December 2019

    Clinical trial networks for antibiotic development

    DownloadPDF 987KB

    The results from our workshop exploring the use of clinical trial networks for antibiotic development and why they’re important.

    Report 1 September 2016 Updated 4 December 2019

    Evidence for action on antimicrobial resistance

    DownloadPDF 3.1MB

    We propose concrete interventions to combat the real and growing threat of antimicrobial resistance.

    Report Updated 4 December 2019

    Exploring terminology and naming for controlled human infection models

    DownloadPDF 415KB

    The current language used to describe controlled human infection models is complex, with many different names being used. This report highlights what the issues and possible solutions are.